Multimodal prehabilitation in colorectal cancer patients to improve functional capacity and reduce postoperative complications: the first international randomized controlled trial for multimodal prehabilitation
Stefanus J. van Rooijen(Radboud University Nijmegen), Gerrit D. Slooter(Radboud University Nijmegen), Rudi M. H. Roumen(Radboud University Nijmegen), Sandra Beijer, Graciela Martínez‐Palli(Hospital Clínic de Barcelona), Gwendolyn A. Thomas(Radboud University Nijmegen), Nicolas Barizien(Hôpital Foch), Carlo V. Feo(University of Ferrara), Francesco Carli(McGill University Health Centre), Rashami Awasthi(Montreal General Hospital), Enrico Maria Minnella(Montreal General Hospital), Celena Scheede‐Bergdahl(McGill University), Susanne Oksbjerg Dalton(University of Copenhagen), Christoffer Johansen(University of Copenhagen), Ismail Gögenür(University of Copenhagen), Rasmus Dahlin Bojesen(Slagelse Hospital), Goof Schep, Morgan Le Guen(Hôpital Foch), Rianne van Lieshout(Radboud University Nijmegen)
Cited by 362
Related Papers
Cytotoxic CD8+ T cells in cancer and cancer immunotherapy
|British Journal of Cancer|2020|1.7k
Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study
|The Lancet Oncology|2014|477
The Safety of Melatonin in Humans
|Clinical Drug Investigation|2015|464
Effect of Multimodal Prehabilitation on Reducing Postoperative Complications and Enhancing Functional Capacity Following Colorectal Cancer Surgery
|JAMA Surgery|2023|434
Clinical pharmacokinetics of melatonin: a systematic review
|European Journal of Clinical Pharmacology|2015|306